Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2025-02-01
DOI
https://doi.org/10.1136/bmjopen-2024-088449
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

Subhasish Das, Dilruba Ahmed, Firdausi Qadri, Elena Fernández Álvaro et al.
BMJ Open
Antibiotic Resistance in Bacteria
article

Tebipenem pivoxil as an alternative to ceftriaxone for clinically non-responding children with shigellosis: a randomised non-inferiority trial protocol

Subhasish Das, Dilruba Ahmed, Firdausi Qadri, Elena Fernández Álvaro, Samuel L.M. Arnold, Patricia B. Pavlinac, Juliet Addo, Syed Khairul Bashar, Sharika Nuzhat, Farhana Khanam, Rachel A. Gibson, Md Ridwan Islam, Tahmeed Ahmed, Mohammod Jobayer Chisti, Amy Newlands
article en

Abstract

No abstract available for this paper.
BMJ OpenVol. 15(2)
GlaxoSmithKline (United Kingdom) (GB), University of Washington (US), International Centre for Diarrhoeal Disease Research (BD), Age UK (GB)
Good health and well-being
Openalex Percentile: Top 97%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.